Skip to content
10-Q

Quarterly Report

BioCrude Technologies USA, Inc.

0001731122-25-001111

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 14, 2025 50.85M sh
Shares Diluted Q2 2025 · Jun 30, 2025 50.8M sh
Shares Diluted Q2 2025 · Jun 30, 2025 50.8M sh
Shares Diluted Q2 2025 · Jun 30, 2024 50.8M sh
Shares Diluted Q2 2025 · Jun 30, 2024 50.8M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$57.84K
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$165.47K
Short Term Debt Q2 2025 · Jun 30, 2025 $136.09K
Short Term Debt Q2 2025 · Dec 31, 2024 $130.64K
Stockholders Equity Q2 2025 · Jun 30, 2025 −$406.22K
Stockholders Equity Q2 2025 · Dec 31, 2024 −$299.03K
Current Liabilities Q2 2025 · Jun 30, 2025 $421.5K
Current Liabilities Q2 2025 · Dec 31, 2024 $322.13K
Total Liabilities Q2 2025 · Jun 30, 2025 $421.5K
Total Liabilities Q2 2025 · Dec 31, 2024 $322.13K
Current Assets Q2 2025 · Jun 30, 2025 $196
Current Assets Q2 2025 · Dec 31, 2024 $5.2K
Total Assets Q2 2025 · Jun 30, 2025 $11.66K
Total Assets Q2 2025 · Dec 31, 2024 $19.09K
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2024 $0.00
Eps Diluted Q2 2025 · Jun 30, 2024 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2024 $0.00
Eps Basic Q2 2025 · Jun 30, 2024 $0.00
Sga Expense Q2 2025 · Jun 30, 2025 $41.48K
Sga Expense Q2 2025 · Jun 30, 2025 $99.22K
Sga Expense Q2 2025 · Jun 30, 2024 $63.6K
Sga Expense Q2 2025 · Jun 30, 2024 $186.21K
Net Income Q2 2025 · Jun 30, 2025 −$47.04K
Net Income Q2 2025 · Mar 31, 2025 −$58.65K
Net Income Q2 2025 · Jun 30, 2024 −$64.47K
Net Income Q2 2025 · Mar 31, 2024 −$123.54K
Operating Income Q2 2025 · Jun 30, 2025 −$41.48K
Operating Income Q2 2025 · Jun 30, 2025 $99.22K
Operating Income Q2 2025 · Jun 30, 2024 −$63.6K
Operating Income Q2 2025 · Jun 30, 2024 −$186.21K